A top podcast for healthcare leaders, with over one million downloads, Radio Advisory is your weekly download on how to untangle the industry's most pressing challenges to help leaders like you make the best business decisions for your organization. From unpacking major trends in care delivery—like site-of-care shifts and the rise of high-cost drugs—to demystifying stakeholder dynamics, to shining a spotlight on priorities that may get overlooked, we're here to help. Our hosts and seasoned r ...
…
continue reading
Kandungan disediakan oleh EMJ. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh EMJ atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !
Pergi ke luar talian dengan aplikasi Player FM !
Bonus Episode: Contemporary BCG Side Effect Management
MP3•Laman utama episod
Manage episode 449645295 series 3412919
Kandungan disediakan oleh EMJ. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh EMJ atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
This content has been funded by medac.
In this new insightful podcast, expert in oncological urology Fred Witjes, Radboud University, Nijmegen, the Netherlands, sits down to discuss management of the side effects that follow Bacillus Calmette-Guérin (BCG). Witjes dives into the absolute and relative contraindications for BCG installation, and explores some of the real-world reasons for BCG treatment discontinuation, before delving into what the signs that clinicians should look out for in their patients, and the procedures they can follow to reduce adverse events after BCG. Other topics discussed include:- Reducing the rate of lower urinary tract symptoms-related BCG treatment discontinuation;
- How to increase the confidence of urologists regarding BCG side effect management;
- How to make adequate use of the major drug classes used in the management of BCG side effects; and
- When healthcare professionals should make the call to switch treatments.
200 episod
MP3•Laman utama episod
Manage episode 449645295 series 3412919
Kandungan disediakan oleh EMJ. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh EMJ atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
This content has been funded by medac.
In this new insightful podcast, expert in oncological urology Fred Witjes, Radboud University, Nijmegen, the Netherlands, sits down to discuss management of the side effects that follow Bacillus Calmette-Guérin (BCG). Witjes dives into the absolute and relative contraindications for BCG installation, and explores some of the real-world reasons for BCG treatment discontinuation, before delving into what the signs that clinicians should look out for in their patients, and the procedures they can follow to reduce adverse events after BCG. Other topics discussed include:- Reducing the rate of lower urinary tract symptoms-related BCG treatment discontinuation;
- How to increase the confidence of urologists regarding BCG side effect management;
- How to make adequate use of the major drug classes used in the management of BCG side effects; and
- When healthcare professionals should make the call to switch treatments.
200 episod
Alle episoder
×Selamat datang ke Player FM
Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.